Cashu | News | BIIB

HomeWatchlistNewsSignalsPicks

DJI

-0.18%

SPX

-0.06%

IXIC

+0.13%

FTSE

-0.43%

N225

+0.73%

AXJO

+0.22%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Stocks

Health Care

biib

Biogen

NASDAQ: BIIB

-2.23 (-1.64%)

134.13

USD

At close at Aug 28, 14:03 UTC

Latest Biogen News

J&J Commits $2 Billion To US Manufacturing Expansion Amid Threat Of Drug Tariffs

Feature Image for interests on CryptoCurrency, Economics, Government, Health Care from benzinga.com

This biotech stock could see a sharp swing higher after years of struggling, charts suggest

Feature Image for interests on Breaking News: Markets, Healthcare, Markets, Stock from cnbc.com

Novo Nordisk Surges On Wegovy Win, Eyes Bullish Rebound Near 52-Week Lows

Analyst Expectations For Biogen's Future

Eli Lilly To Raise Mounjaro Price In UK, Expands Obesity Drug Push In India

Feature Image for interests on Biotech, Health Care, Healthcare, India from benzinga.com

How Novo Nordisk's Weight-Loss Drug Could Unlock A Better Future For Biogen's Alzheimer's Treatment

Feature Image for interests on Biotech, Expert Ideas, Healthcare, Large Cap from benzinga.com

Beyond The Numbers: 8 Analysts Discuss Biogen Stock

Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?

Feature Image for interests on Basic Materials, Benzinga Pro, Consumer Cyclical, CryptoCurrency from benzinga.com

Stocks making the biggest moves midday: Generac, Shake Shack, Microsoft, Meta & more

Feature Image for interests on Breaking News: Markets, Business, Communication Services, Consumer Cyclical from cnbc.com

Biogen Lifts Outlook As Rare Disease And Alzheimer's Drug Sales Accelerate

Feature Image for interests on Biotech, Earnings, Healthcare, Large Cap from benzinga.com

Latest Cashu News

Biogen's Industry Response: JNJ Invests $2 Billion in U.S. Manufacturing Amid Regulatory Changes

Biogen's Cup-and-Handle Pattern Signals Potential Rebound Despite Historical Caution

Biogen's Stock Shows Signs of Recovery Amid Technical Breakout Potential